Keyphrases
Parkinson's Disease
100%
Positron Emission Tomography
22%
Huntington's Disease
21%
Dystonia
18%
Alpha-synuclein (α-syn)
17%
Parkinsonism
16%
Nonhuman Primate
13%
Levodopa
12%
Deep Brain Stimulation
12%
Striatal
10%
Radioligand
10%
Manganese
10%
Cervical Dystonia
10%
Idiopathic Parkinson's Disease
10%
Unified Parkinson's Disease Rating Scale (UPDRS)
10%
Dopamine
9%
Confidence Interval
9%
Alzheimer's Disease
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
8%
Neurodegenerative Diseases
8%
Receptor Binding
8%
Radiotracer
7%
Parkinson Patients
7%
Manganese Exposure
7%
Vesicular Acetylcholine Transporter (VAChT)
7%
D2 Receptor
7%
Patients with Parkinson's Disease
7%
Striatum
7%
Age of Onset
7%
Macaque
6%
Regional Cerebral Blood Flow (rCBF)
6%
Pathophysiology
6%
Basal Ganglia
6%
Movement Disorders
6%
Monkey
6%
Tremor
5%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Odds Ratio
5%
Baboon
5%
Welders
5%
Medicare Beneficiaries
5%
Subthalamic nucleus
5%
Premanifest Huntington's Disease
5%
Radiosynthesis
5%
Gait
5%
Dopamine D2 Receptor (DRD2)
5%
Dementia
5%
Sphingosine-1-phosphate Receptor (S1PR)
5%
Botulinum Neurotoxin (BoNT)
5%
Neuroscience
Parkinson's Disease
91%
Positron Emission Tomography
25%
Dystonia
19%
Fluorine-18
18%
In Vivo
15%
Parkinsonism
15%
Deep Brain Stimulation
14%
Huntington's Disease
14%
Positron Emission Tomography
12%
Receptor
11%
L-DOPA
11%
Dopaminergic
10%
Alzheimer's Disease
10%
Subthalamic Nucleus
10%
Radioligand
10%
Tremor
10%
Behavior (Neuroscience)
9%
Synuclein
9%
In Vitro
8%
Stereotypic Movement Disorder
8%
Basal Ganglia
8%
Neurodegenerative Disorder
7%
Putamen
7%
Amyloid Protein
7%
Receptor Binding
7%
Spasmodic torticollis
7%
Striatum
6%
Cerebellum
6%
Magnetic Resonance Imaging
5%
Vesicular Acetylcholine Transporter
5%
Functional Magnetic Resonance Imaging
5%